IVI and KAVI-ICR Conduct Investigator Meeting for Upcoming Phase 2 Cholera Vaccine Study in Nairobi
Nairobi, Kenya – The International Vaccine Institute (IVI), in collaboration with the KAVI – Institute of Clinical Research (KAVI-ICR), successfully concluded an Investigator Meeting in preparation for an upcoming Phase 2 Cholera Vaccine Clinical Trial in Nairobi.
Why It Matters